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Abstract
Background: Burkholderia gladioli pathovar cocovenenans (BGC) is responsible for sporadic food-poisoning
outbreaks with high morbidity and mortality in Asian countries. Little is known about the regulation of virulence
factor and toxin production in BGC, and studies in this bacterium have been hampered by lack of genetic tools.
Findings: Establishment of a comprehensive antibiotic susceptibility profile showed that BGC strain ATCC33664 is
susceptible to a number of antibiotics including aminoglycosides, carbapenems, fluoroquinolones, tetracyclines and
trimethoprim. In this study, we established that gentamicin, kanamycin and trimethoprim are good selection
markers for use in BGC. Using a 10 min method for preparation of electrocompetent cells, the bacterium could be
transformed by electroporation at high frequencies with replicative plasmids containing the pRO1600-derived
origin of replication. These plasmids exhibited a copy number of > 100 in BGC. When co-conjugated with a
transposase expressing helper plasmid, mini-Tn7 vectors inserted site- and orientation-specifically at a single
glmS-associated insertion site in the BGC genome. Lastly, a Himar1 transposon was used for random transposon
mutagenesis of BGC.
Conclusions: A series of genetic tools previously developed for other Gram-negative bacteria was adapted for use
in BGC. These tools now facilitate genetic studies of this pathogen and allow establishment of toxin biosynthetic
pathways and their genetic regulation.
Background
Burkholderia gladioli pathovar cocovenenans was first
described in the 1960 s as a bacterium that caused
severe cases of food-poisoning and was then named
Pseudomonas cocovenenans [1]. It has been re-named
several times since. In 1995 the bacterium was named
B. cocovenenans [2,3] and in 1999 it was combined with
B. gladioli, a phytopathogenic bacterium [4]. Though
later analyses confirmed that B. cocovenenans and
B. gladioli should be categorized as a single species, it
was deemed necessary to distinguish those strains that
a r ep h y t o g e n i cf r o mt h o s et h a ta l s op r o d u c et o x i n s
lethal to mammals. This resulted in designation of a
new pathovar, B. gladioli pathovar cocovenenans (BGC)
in 2003 [5].
Outbreaks of severe BGC-caused food-poisoning are
sporadic and seem to be confined to Asia. In endemic
regions, fermented coconut can be contaminated with
BGC, hence the name “cocovenenans”. In particular,
bacterial derived toxins have been implicated in deaths
resulting from eating the soybean and coconut-based
product known as tempe bongkrek. Unlike food-poison-
ing caused by other bacteria, e.g. E. coli O157:H7, mor-
tality rates are significant, reaching > 40% during an
outbreak in China in the 1970’s [6,7]. Though tempora-
rily called Flavobacterium farinofermentans [8], it
was later shown that this bacterium was identical to
P. cocovenenans [9]. Initial symptoms of BGC-caused
food-poisoning are evident after a 4-6 hour incubation
period and typically include abdominal pains, general
malaise, extensive sweating, tiredness and sleepiness,
followed by coma. Death usually occurs within 1 to 24
hours after onset of initial symptoms. Diagnosis of the
disease is unreliable. This is perhaps best illustrated by a
2007 episode of food-poisoning reported in Central Java
(Indonesia)(ProMed Archive numbers 20070802.2439
and 20070806.2557). While this particular episode was
first attributed to BGC, this was later doubted and
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BGC produces two potent toxins, yellow toxoflavin
and colorless bongkrekig acid (BA; also known as bonk-
rek acid). Though it is not entirely clear whether both
toxins contribute to human disease, the evidence points
to BA as the major toxin as other bacteria expressing
significant levels of toxoflavin, e.g. the rice pathogen
B. glumae, do generally not cause human disease [10]. A
crude toxin preparation (basically supernatant of plate-
grown cells) kills mice within 45 min upon oral admin-
istration [5]. Toxoflavin production, its biosynthetic
pathways and regulatory mechanisms have been studied
at the molecular level in B. glumae [10]. In contrast,
very little is known about toxoflavin and BA production
in BGC. A single study showed that BA production is
stimulated when BGC is grown in the presence of cer-
tain unsaturated fatty acids [11]. Molecular studies in
BGC are hindered by lack of genetic tools and in this
study we extended the arsenal of tools previously devel-
oped for P. aeruginosa, B. pseudomallei and other
Gram-negative bacteria to BGC.
Results and Discussion
Determination of antibiotic susceptibility profiles
As most genetic manipulation methods rely on antibio-
tic selection, it was paramount to determine the antibio-
tic susceptibility profile of BGC strain ATCC33664
(Table 1). The findings show that this BGC strain is sus-
ceptible to aminoglycosides (e.g. gentamicin, kanamycin
and streptomycin), carbapenems (e.g. imipenem and
meropenem), fluoroquinolones (e.g. ciprofloxacin and
norfloxacin), tetracyclines (e.g. doxycycline and tetracy-
cline) and trimethoprim, butq u i t er e s i s t a n tt om a n y
other antibiotics including many b-lactams (e.g. ampi-
cillin, amoxicillin, carbenicillin, and ceftazidime),
macrolides (e.g. clarithromycin, clindamycin and ery-
thromycin), chloramphenicol, polymyxin B and zeocin.
Many cloning and transposon vectors contain aminogly-
coside, tetracycline or trimethoprim resistance selection
markers and, because of BCG’s susceptibility to the
respective antibiotics, should thus be applicable in this
bacterium.
Transformation by electroporation
A prerequisite for any genetic manipulation is the ability
to deliver exogenous DNA, e.g. plasmids, into the tar-
geted host strain. The two most commonly used meth-
ods are electroporation or conjugation. We previously
developed a rapid method for preparation of electro-
competent P. aeruginosa cells [12] which was subse-
quently adapted for use in B. pseudomallei [13]. We
therefore tested the method in BGC strain ATCC33664.
Using the standard method detailed in the Methods
section, this strain was subjected to electrotransforma-
tion with pUCP28T or pUCP30T. These and other plas-
mids based on the pRO1600 replicon were previously
shown to replicate in other Burkholderia species [13,14].
Selection on LB plates containing 100 μg/ml trimetho-
prim (pUCP28T) or 30 μg/ml gentamicin (pUCP30T) by
incubation for two days at 30°C resulted in a transfor-
mation efficiency of 10
6 and 10
7 colony forming units/
μg of input DNA which is comparable to efficiencies
seen with P. aeruginosa [12]. The copy number of
pUCP30T in log phase BGC strain ATCC33664 cells
growing in LB medium was > 100 as determined by
using a previously described quantitative real-time PCR
method [13,15]. This is in contrast to B. pseudomallei
where the copy number of pRO1600 replicon-containing
plasmids was determined to be 3-4 [13]. The results
indicated that pUCP28T and pUCP30T can efficiently
be transformed into BGC, replicate in this bacterium at
a fairly high copy number and can thus be used to over-
express genes cloned into these plasmid vectors.
Application of the mini-Tn7 system in BGC
Transposon Tn7 based mini-Tn7 vectors exhibit several
features distinct from plasmid vectors: 1) they integrate
into the chromosome site- and orientation-specifically
and are thus maintained in single-copy; 2) because they
Table 1 Antibiotic susceptibilities of BGC strain
ATCC33664
Antibiotic MIC (μg/ml)
Ampicillin 64
Amoxicillin 256
Carbenicillin 64
Ceftazidime 32
Imipenem 4
Meropenem 0.75
Ciprofloxacin 0.5
Norfloxacin 8
Clindamycin > 1024
Clarithromycin 128
Erythromycin 128
Gentamicin 0.125
Kanamycin 0.25
Streptomycin 8
Doxycycline 4
Tetracycline 8
Trimethoprim 0.125
Polymyxin B > 1024
Zeocin 256
Antibiotic susceptibilities were either determined using E-test (imipenem,
meropenem and trimethoprim) or the two-fold serial microdilution method
(all others).
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only require antibiotic selection for initial selection of
the transposition event; 3) they are broad-host-range
and their use is only limited by availability of delivery
vehicle transfer method (electroporation or conjugation)
and selection marker; and 4) detailed methods for trans-
poson delivery and integration site mapping have been
described [16-19].
To assess the utility of mini-Tn7 based vectors in
BGC, the helper plasmid pTNS3 [13] and the mini-Tn7
delivery vector pUC18T-mini-Tn7T-Gm-REP [18] were
transformed into E. coli mobilizer strain RHO3 and con-
jugations with BGC performed as previously described
[20]. Co-conjugation of both helper and delivery plas-
mids into BGC strain ATCC33664 followed by selection
on LB agar plates containing 30 μg/ml gentamicin
resulted in numerous gentamicin resistant transformants
after incubation at 30°C for two days. Because BGC’s
genome sequence is unknown, we used a previously
described method for mapping the Tn7 insertion site(s)
[17] as detailed in the methods section. Sequencing of
DNA flanking the transposon left and rights ends
revealed that the insertions occurred either between
nucleotides 24 and 25 or 25 and 26 downstream of a
putative glmS gene (Figure 1). This insertion site and
distance from glmS is consistent with what has been
observed in other bacteria as mini-Tn7 elements almost
always insert downstream of glmS, although rare excep-
tions do exist [19]. This insertion site was verified in six
distinct gentamicin resistant transformants using the
Figure 1 mini-Tn7 insertion site in BGC. A) The mini-Tn7 insertion site in BGC strain ATCC33664 determined from rescued plasmids. The
sequence shown encompasses the last five codons of a putative glmS gene and its immediate downstream sequence, including the mini-Tn7
insertion sites 24 and 25 nucleotides downstream of the glmS stop codon. B) Presence of a single insertion site in BGC. Boiled cell lysates were
prepared from six gentamicin resistant transformants obtained after transposition of mini-Tn7T-Gm-REP into BGC. Chromosomal DNA contained
in boiling preparation lysates was used as a template in PCR reactions containing PTn7L and PTn7 BGC. The lane labeled M contained Hi-Lo
molecular weight markers from Minnesota Molecular (Minneapolis, MN). All other lanes contain PCR products from six gentamicin resistant
transformants.
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to the transposon left end (PTn7L)(Figure 1). The
expected 355 bp PCR fragment was observed in all six
transformants and sequencing confirmed the expected
Tn7 insertion sites either after nucleotide 24 or 25
downstream of the glmS stop codon. Since all Burkhol-
deria species analyzed to date contained multiple glmS
genes and thus multiple mini-Tn7 insertion sites
[13,16,17], boiling lysates were prepared from 90 genta-
micin resistant transformants and used as templates in
PCR reactions with PTn7-BGC and PTn7L. Observation of
the same PCR fragment in all tested transformants indi-
cated a single mini-Tn7 insertion site in BGC (data not
shown). We were unable to obtain gentamicin resistant
transformants in a second transposition event using a
strain with an existing insertion at the glmS-associated
site but having the gentamicin resistance marker deleted
by site-specific recombination using Flp recombinase.
The overall experimental evidence corroborates the
notion of BGC having only one glmS-associated mini-
Tn7 insertion site which can be used for efficient, site-
specific insertion of mini-Tn7 elements.
Flp recombinase-mediated marker excision from
chromosomally-inserted DNA
Site-specific recombinases, usually yeast Flp recombinase
or bacteriophage P1 Cre recombinase, can be used for
site-specific excision (deletion) of DNA fragments
flanked by the cognate recombination sites, i.e. Flp
recombinase target (FRT) sites for Flp or loxP sites for
Cre [21]. We previously demonstrated use of Flp and
Cre recombinases in various bacteria, including B. pseu-
domallei, for derivation of markerless mutants [13,22].
Excision of antibiotic selection markers allows recycling
of the same resistance determinants in subsequent
genetic manipulation procedures. To assess efficiency of
Flp recombinase mediated marker excision, we trans-
formed the Flp expression plasmid pFLPe4 into a genta-
micin resistant BGC strain containing a chromosomally
integrated mini-Tn7T-Gm-REP element. On this plas-
mid, expression of the enhanced Flp structural gene is
under control of a rhamnose-regulated promoter [13].
When transformants were plated on LB plates contain-
ing 35 μg/ml kanamycin and 0.2% rhamnose, the genta-
micin marker was efficiently excised (all kanamycin
resistant transformants were gentamicin susceptible).
Furthermore, pFLPe4 was rapidly cured from cells
grown at 37°C indicating the temperature-sensitive
origin of replication contained on this plasmid is func-
tioning at permissive temperature (30°C) but not the
non-permissive (37°C) temperature. We conclude that
site-specific recombinases can be used in BGC for effi-
cient excision of antibiotic resistance markers from
chromosomally integrated DNA elements. Although we
have not yet tried Cre recombinase it can be assumed
that the Cre/loxP system will function in BGC as well.
Himar1 random mutagenesis
Random transposon mutagenesis is a powerful tool for
generation of mutants useful for pathogenesis and other
studies. We previously described an efficient in vivo
Himar1 transposon mutagenesis system for B. pseudo-
mallei and demonstrated its use for the isolation of aux-
otrophic and other mutants [23]. Mariner-based
transposons function in many bacteria since they do not
require host-specific factors and, other than preference
for a TA dinucleotide target, do not display target site
specificity. To assess the utility of Himar1 transposition
system in BGC, we transformed pHBurk3 [23] into
strain ATCC33664 by electroporation and selected
kanamycin resistant transformants at 37°C. At this tem-
perature, pHBurk3 does not replicate and kanamycin
resistant colonies should only arise by transposition
of the Himar1 transposon into chromosomal DNA.
Electroporation of 300 ng of pHBurk3 into BGC
ATCC33664 yielded 1.6 × 10
4 kanamycin resistant colo-
nies at the non-permissive temperature (37°C) and 3.6 ×
10
4 kanamycin resistant colonies at the permissive tem-
perature (30°C). The calculated rate of transposition is
therefore 44%, similar to what has been observed with
B. pseudomallei [23]. Twenty kanamycin resistant colo-
nies were picked, chromosomal DNA isolated and sub-
jected to genomic Southern analysis using a transposon-
specific probe. An analysis of chromosomal DNA from
nine colonies is shown in Figure 2. It is evident that the
Himar1 transposon inserts randomly in chromo-
somal DNA and there is a low propensity for double
Figure 2 Random transposition of Himar1 in BGC. Genomic DNA
was prepared from nine randomly selected kanamycin resistant
transformants, digested for 3 h with NotI, and transferred to a nylon
membrane. The membrane was hybridized with a probe that
detected oriR6K on the transposon. DNA from BGC strain ATCC33664
was included as a negative control (lane -). The positive control
(lane P) was pHBurk3. The 7-, 5-, 3- and 2-kb fragments contained in
the biotinylated 2-log DNA ladder (New England Bio-Labs) are
indicated on the left. The two hybridizing fragments observed in
lanes 5 and 7 are indicative of double Himar1 insertions in the
respective mutants.
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had double insertions (two of them were included in
Figure 2, lanes 5 and 7). A preliminary analysis of
~1,700 mutants by replica plating on M9 glucose mini-
mal medium showed a surprisingly low (0.12%) auxotro-
phy rate. This compares to a rate of 0.72% observed for
B. pseudomallei [23]. Because the Himar1 transposon
located on pHBurk3 contains an R6K origin of replica-
tion and a kanamycin resistance selection marker, self-
ligation of chromosomal DNA fragments obtained by
digestion with a restriction enzyme that does not cleave
transposon DNA allows rescue of replicating plasmids
after transformation of an E. coli strain expressing the π
protein. Plasmid rescue was performed from one of the
auxotrophic mutants and DNA sequencing revealed that
the insertion occurred within the amidophosphoribosyl-
transferase structural gene purF. Nutritional supplemen-
tation experiments with adenine restored growth of the
mutant on M9 glucose minimal medium and supported
the functional assignment of purF within the de novo
purine biosynthetic pathway. The experimental evidence
shows that the Himar1 transposon can be used in BGC
for generation of random chromosomal mutations.
Conclusions
We have shown that many of the tools previously devel-
oped for other Burkholderia species function efficiently
in BGC and can thus be used for genetic manipulation
of this bacterium, and probably the closely related phy-
topathogenic B. gladioli. Determination of the antibiotic
susceptibility profiles indicated that aminoglycosides
(gentamicin and kanamycin) as well as trimethoprim
resistance markers provide a clean selection in BGC
using relatively low antibiotic levels. This was initially
demonstrated by successful electroporation of two repli-
cative plasmids, pUCP28T and pUCP30T, using a rapid,
microcentrifuge-based procedure for preparation of elec-
trocompetent cells. Co-conjugation of a helper and
delivery plasmid from E. coli to BGC showed that mini-
Tn7 elements can be readily transposed into the BGC
genome. Unlike other Burkholderia species, BGC seems
to contain only one glmS-linked insertion site. Transpo-
sition events can readily be monitored by developments
of a BGC-specific primer and defined PCR conditions.
Site-specific excision of the gentamicin resistance mar-
ker from the chromosomally-integrated mini-Tn7 ele-
ment using Flp recombinase proved the functionality of
the Flp/FRT system for marker excision in BGC and
rapid curing of the Flp expression plasmid at non-per-
missive temperature. Lastly, we established that the
mariner based Himar1 transposon can be used for
rapid, random mutagenesis of the BGC genome. The
tools and methods described here provide the basis for
genetic manipulation and modification of BGC,
something that was to date unachievable. The authors
realize that the conclusions relating to the applicability
of the methods to the species are based on a single iso-
l a t e .H o w e v e r ,al i m i t e dn u m b e ro fB G Cs t r a i n sa r e
available and it is likely that most studies will be per-
formed using the type strain, ATCC33664, used in this
study.
Methods
Bacterial strains, media and growth conditions
B. gladioli pathovar cocovenenans (BGC) ATCC33664
was obtained from the American Type Culture Collec-
tion, Manassas, VA. E. coli strains used were DH5a
(lpir)(laboratory collection) and RHO3 [20]. RHO3 is a
Δasd mutant and requires 400 μg/ml diaminopimelic
acid (DAP; LL-, DD-, and meso-isomers; Sigma, St.
Louis, MO) for growth on rich media. Bacteria were
routinely grown at 37°C (E. coli) or 30°C (BGC) in Luria
broth Lennox (LB) [24] or on LB agar purchased from
MO BIO Laboratories, Carlsbad, CA. Strains containing
temperature-sensitive (TS) plasmid derivatives or TS
alleles were grown at 30°C (permissive temperature) or
37°C (non-permissive temperature). M9 medium [25]
with 10 mM glucose was used as the minimal medium
and supplemented with 0.6 mM adenine to support
growth of purF mutants. Antibiotics were added at the
following concentrations: 100 μg/ml ampicillin, 15 μg/
ml gentamicin and 35 μg/ml kanamycin for E. coli;1 5 -
30 μg/ml gentamicin and 35 μg/ml kanamycin for BGC.
Minimal inhibitory concentrations (MICs) were deter-
mined in Mueller-Hinton broth (Becton Dickinson,
Franklin Lakes, NJ) by the 2-fold broth microdilution
technique following Clinical and Laboratory Standards
Institute guidelines [26]. The MICs were recorded after
incubation at 30°C for 24 h. Antibiotics were purchased
from the following manufacturers: carbenicillin was
from Duchefa Biochemie via Gold Biotechnology, St.
Louis, MO; ciprofloxacin was from LKT Laboratories,
St. Paul, MN; gentamicin was from EMD Biosciences,
San Diego; zeocin was from Invitrogen, Carlsbad, CA;
and all others were from Sigma, St. Louis, MO.
DNA and genetic methods
Details of most of the methods described herein have
previously been described and adapted for use in BGC
with minor modifications.
Plasmids
Plasmid DNAs were isolated from E. coli and Burkhol-
deria spp. by using a Fermentas GeneJET Plasmid Mini-
Prep Kit (Fermentas, Glen Burnie, MD). Plasmids used
in this study included the replicative pUCP28T [14],
pUCP30T [14] and pFLPe4 [13]. The non-replicative
plasmids pTNS3 [13], pUC18T-mini-Tn7T-Gm-REP
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site-specific transposition pathway, mini-Tn7T-Gm-REP,
and Himar1 transposon, respectively. The GenBank
accession numbers for plasmids are U33751 for
pUCP28T; U33752 for pUCP30T; EU215438 for
pFLPe4; EU215432 for pTNS3; AY712952 for pUC18T-
mini-Tn7T-Gm-REP and EU919403 for pHBurk3.
Electrocompetent cells, transformation and plasmid
copy number
Bacterial cells were made competent by a rapid method
[12]. Briefly, cells were grown overnight at 30°C and 1 ml
of this culture was harvested by centrifugation in a
microfuge at 8,000 rpm for 2 min. The cells were washed
twice with 1 ml of sterile 300 mM sucrose by resuspen-
sion with a pipet tip and centrifugation at 8,000 rpm for
2 min. Cells were finally resuspended in 100-200 μlo f
300 mM sucrose. All solutions and manipulation steps
were at room temperature. One hundred microliter ali-
quots of electrocompetent cells were then used in elec-
troporation experiments using previously described
conditions, except that after electroporation cells were
incubated at 30°C for 1 h prior to plating on selective
media. BGC cells were typically transformed with 100 to
200 ng of plasmid DNA. A quantitative real-time PCR
method was used for determination of plasmid copy
number in BGC [13,15]. With this method, the separate
detections of a plasmid and host chromosomal DNA
were achieved using two separate primer sets, specific for
the plasmid aminoglycoside resistance gene (aacCI)a n d
for the chromosomal, single-copy aspartate-b-semialde-
hyde dehydrogenase gene (asd). Primers were designed
using Primer 3 software and were as follows: for aacC1,
aacC1-Q-F (5’-CTGATGTTGGGAGTAGGTG) and
aacC1-Q-R (5’-GTTAGGTGGCTCAAGTATGG), yield-
ing an 130-bp product; and for asd,a s d - R T - U P
(5-ACACGTCGTTCGTGTAGTCG) and asd-RT-DN
(5 AAAACGAGACCACGCTCAAG), yielding a 99-bp
product. Real-time quantitative PCR amplifications of the
total DNA samples from two separate BCG ATCC33664
cultures harboring pUCP30T were performed. The abso-
lute copy numbers of aacC1 and asd genes in the BGC
total DNA samples were determined from the respective
standard curves, using the threshold cycle values. The
plasmid copy numbers of pUCP30T was calculated by
dividing the absolute copy number of aacC1 by the copy
number of asd. Experiments were repeated three times
for calculation of copy number.
Transposition of mini-Tn7 and determination of
insertion site
The helper plasmid pTNS3 [13] and the mini-Tn7 deliv-
ery vector pUC18T-mini-Tn7T-Gm-REP [18] were
transformed into E. coli mobilizer strain RHO3 [20].
Co-conjugation of both helper and delivery plasmids
into BCG strain ATCC33664 was achieved by triparental
mating. E. coli and BGC cultures were grown overnight
at 37°C or 30°C, respectively. 200 μl of each culture was
transferred to the same microcentrifuge tube and cells
harvested by centrifugation at 8,000 rpm at room tem-
perature. Cells were washed twice with LB medium and
then resuspended in 30 μlo fL B .T h ec e l ls u s p e n s i o n
was transferred to a filter sitting on an LB agar plate
containing 400 μg/ml DAP. After overnight incubation
at 30°C, the filter was transferred to a microcentrifuge
tube containing 1 ml of LB and cells dislodged by vor-
texing for 60 s. Aliquots (50 and 100 μl) were spread on
LB-agar plates with 30 μg/ml gentamicin and plates
incubated at 30°C for two days. For insertion site map-
ping, we used a previously described method [17].
Briefly, six gentamicin resistant transformants were
grown overnight in LB medium with 30 μg/ml gentami-
cin and genomic DNA was isolated using a PUREGENE®
genomic DNA purification kit (Gentra Systems, Minnea-
p o l i s ,M N ) .1μgo ft h i sD N Aw a st h e nd i g e s t e dw i t h
NotI for 2 h and the resulting DNA fragments were self-
ligated overnight at 14°C. The ligation mixtures were
transformed into DH5a(lpir) and gentamicin resistant
transformants selected by plating on LB medium with
15 μg/ml gentamicin. Plasmid DNA was then isolated
from transformants grown in LB medium with 15 μg/ml
gentamicin and sequenced using either PTn7L or PTn7R
as a primer. After insertion site mapping, a BGC-specific
primer (PTn7-BGC;5 ’-GGAACAGGCTGAAACGAGAG)
was used in conjunction with PTn7L (5’-ATTAGCTTAC-
GACGCTACACCC;[18]) to rapidly identify transfor-
mants with mini-Tn7 insertions at this glmS-associated
site by colony PCR using DNA in boiling preparation
lysates as templates. These lysates were obtained by
transferring separate colonies to individual sterile micro-
centrifuge tubes containing 30 μlo fs t e r i l eH 2Oa n d
boiling for 5 min. Insertions at this site are characterized
by amplification of a 355 bp DNA fragment (Figure 1B).
Flp mediated excision of antibiotic selection markers
and curing of expression plasmid
Flp-mediated excision of chromosomally inserted genta-
micin resistance markers was achieved using previously
described procedures and pFLPe4 [13]. Briefly, cells
were transformed with 150 ng pFLPe4 DNA and kana-
mycin resistant cells selected at 30°C on LB plates with
35 μg/ml kanamycin and 0.2% rhamnose to promote
FLP gene expression. Kanamycin resistant transformants
were struck for single colonies onto the same selective
plates and colonies were then patched on LB and LB +
30 μg/ml gentamicin plates, followed by incubation at
30°C. Gentamicin susceptible colonies indicate success-
ful excision of the gentamicin resistance marker. For
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inoculated into LB medium and grown overnight at
30°C. Cells from this culture were then struck onto LB
agar plates for single colonies and the plates incubated
at 37°C. Single colonies growing on these plates were
then patched onto LB, LB + 30 μg/ml gentamicin and
LB + 35 μg/ml kanamycin plates. Cells growing only on
the LB plates were saved.
Himar1 transposition into BCG and insertion site mapping
pHBurk3 is a Himar1 delivery plasmid with a tempera-
ture sensitive origin of replication, a Himar1 transposon
containing a kanamycin resistance selection marker and
an R6K-derived origin of replication [23]. For transposi-
tion into BGC, electrocompetent cells of strain
ATCC33664 were transformed with 300 ng of pHBurk3
DNA and kanamycin resistant colonies selected at 37°C
on LB plates containing 35 μg/ml kanamycin. Kanamy-
cin resistant colonies growing at this temperature repre-
sent cells containing chromosomally inserted Himar1
transposons. For genomic Southern analysis, 20 kanamy-
cin resistant colonies were picked, grown overnight in
LB medium with 35 μg/ml kanamycin and genomic
DNA isolated with the Gentra PUREGENE® DNA purifi-
cation kit. DNA (2 μg) was digested with NotIf o r3h ,
electrophoresed on a 1% agarose gel, and transferred to
positively charged nylon membranes (Roche Diagnostics
Corp., Indianapolis, IN) by passive transfer as previously
described (23). Following transfer and UV fixation, blots
were probed with a PCR fragment biotinylated by ran-
dom hexamer priming following the NEBlot Phototype
labeling and detection kit protocols (New England Bio-
Labs, Beverly, MA). The probe detected the HimarBP
transposon with a 376-bp fragment recognizing the
oriR6K region.
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